Zenghua Fan

Nov 29, 2024 | mdpi.com | Zhi Xu |Zenghua Fan |Jun Gao |Kun Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Nov 1, 2024 | dx.doi.org | Aram Lyu |Zenghua Fan |Matt Clark |Vibha Gurunathan

Regular and Young Investigator Award AbstractsCheckpoint Blockade Therapy 560 Identification and therapeutic target of myeloid-mediated mechanisms of immunotherapy resistance in prostate cancer Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.